NovoCure Ltd — Director's Dealing 2021

Feb 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-02-22

Reporting Person: Weinberg Uri (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-22	Ordinary Shares	M	6500	$7.15	Acquired	34097	Direct
2021-02-22	Ordinary Shares	S	6500	$175.50	Disposed	27597	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-22	Options to Buy Ordinary Shares	$7.15	M	6500	Disposed	2027-02-21	Ordinary Shares (6500.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.

F2: Fully vested as of the date hereof.